Occupational exposure during endovascular aneurysm repair (EVAR) and aortoiliac percutaneous transluminal angioplasty (PTA) procedures.
Algorithms
Angioplasty
Aortic Diseases
/ diagnostic imaging
Endovascular Procedures
Fluoroscopy
Humans
Ilium
/ diagnostic imaging
Occupational Exposure
/ analysis
Phantoms, Imaging
Radiation Exposure
/ analysis
Radiation Protection
/ instrumentation
Radiography, Interventional
Thermoluminescent Dosimetry
Time Factors
Dosimetry
EVAR
Fluoroscopy
Occupational radiation exposure
PTA
Radioprotective drapes
Journal
La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
26
09
2018
accepted:
20
12
2018
pubmed:
24
1
2019
medline:
25
6
2019
entrez:
24
1
2019
Statut:
ppublish
Résumé
The purpose of this study was to determine the radiation exposure of primary interventionalist's different body parts during endovascular aneurysm repair (EVAR) procedures and aortoiliac percutaneous transluminal angioplasty (PTA) procedures and to evaluate the efficacy of a radioprotective drape. Occupational doses for 36 consecutive aortoiliac PTA procedures and 17 consecutive EVAR procedures were estimated using thermoluminescence dosimetry (TLD) chips (TLD-200, Hashaw, Solon, OH). Effective dose (ED) was calculated using the Niklason algorithm. For the evaluation of a 0.25 mm Pb equivalent drape (Ecolab, Saint Paul, Minnesota, USA), experiments were performed using two physical anthropomorphic phantoms (Rando-Alderson Research Labs, CA, USA). Median ED for a typical EVAR and PTA procedure was 4.7 ± 1.4 μSv and 4.4 ± 3.6 μSv, respectively. The highest radiation doses were measured for the operator's hands in both procedures. Moreover, considerable doses were measured to the operator's head, eye lenses and thyroid. Due to the use of the drape, radiation exposure of primary operator's abdominal area, genitals, thyroid and eye lenses was reduced by an average of 59%, 60%, 65% and 59%, respectively. However, dose area product (DAP) and peak skin dose (PSD) were increased by 20% when part of the drape was placed into the X-ray field. During EVAR and PTA procedures, primary operator's organs are exposed to considerable radiation doses. Occupational radiation exposure can be reduced significantly with the proper use of a radioprotective drape.
Identifiants
pubmed: 30673929
doi: 10.1007/s11547-018-00985-8
pii: 10.1007/s11547-018-00985-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
539-545Références
J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-S296
pubmed: 10666287
Radiat Prot Dosimetry. 2004;111(3):271-4
pubmed: 15266088
J Vasc Surg. 2007 Sep;46(3):455-9
pubmed: 17826233
N Engl J Med. 2008 Jan 31;358(5):464-74
pubmed: 18234751
Health Phys. 2009 Sep;97(3):206-11
pubmed: 19667803
Curr Cardiol Rev. 2009 Jan;5(1):1-11
pubmed: 20066141
Cardiovasc Intervent Radiol. 2011 Aug;34(4):717-22
pubmed: 21069332
Catheter Cardiovasc Interv. 2012 Jan 1;79(1):97-102
pubmed: 21520391
Eur J Cardiothorac Surg. 2012 Aug;42(2):254-59; discussion 259-60
pubmed: 22290886
JAMA. 2012 Apr 18;307(15):1621-8
pubmed: 22511690
Radiology. 2012 Jul;264(1):278-84
pubmed: 22550308
Handb Exp Pharmacol. 2012;(210):547-63
pubmed: 22918746
Vasc Endovascular Surg. 2013 Aug;47(6):462-6
pubmed: 23853222
Eur J Vasc Endovasc Surg. 2013 Oct;46(4):424-30
pubmed: 23871303
JACC Cardiovasc Interv. 2013 Oct;6(10):1095-102
pubmed: 24156970
Eur J Vasc Endovasc Surg. 2014 Mar;47(3):268-72
pubmed: 24445087
Eur J Vasc Endovasc Surg. 2014 Oct;48(4):382-90
pubmed: 25042331
Cardiovasc Intervent Radiol. 2015 Jun;38(3):573-8
pubmed: 25280954
N Engl J Med. 2014 Nov 27;371(22):2101-8
pubmed: 25427112
Cardiovasc Intervent Radiol. 2015 Aug;38(4):827-32
pubmed: 25476871
Ann Vasc Surg. 2016 May;33:167-72
pubmed: 26902938
Phys Med. 2016 Aug;32(8):1019-24
pubmed: 27453204
Eur Radiol. 2017 Nov;27(11):4846-4856
pubmed: 28523354
Health Phys. 1994 Dec;67(6):611-5
pubmed: 7960781